Future prospects for artificial blood

Concern about potential infective agents in donated blood has stimulated th e recent development of blood substitutes. Chemically cross-linked hemoglob ins ave already undergoing clinical trials and might soon be ready for rout ine use. New generations of modified hemoglobin are being prepared to modul ate the effects of nitric oxide and oxygen radicals, and artificial red blo od cells are also under development.